Chrome 2001
.
Aetna Intelihealth InteliHealth Aetna Intelihealth Aetna Intelihealth
 
.
. .

   Advertisement
Carepass Ad Carepass Ad .
Chrome 2001
Chrome 2001
Health News Health News
.
Postmenopausal Estrogen Therapy Tied to Lower Glaucoma Risk
January 30, 2014

 

THURSDAY, Jan. 30, 2014 (HealthDay News) -- Women who take estrogen-only hormone-replacement therapy to relieve menopausal symptoms might also be reducing their risk for a common form of the eye disease glaucoma, according to new research.

"Ours is one of the first ... studies to find estrogen-containing hormone-replacement therapy was associated with a reduction in glaucoma risk," said study researcher Dr. Joshua Stein, an assistant professor of ophthalmology at the University of Michigan.

Other studies, however, have come up with conflicting results, Stein said. In his study, he looked at insurance-claims data for women aged 50 and older who were enrolled in a managed care plan for at least four years. The women visited an eye care provider at least twice from 2001 to 2009.

He evaluated information on more than 152,000 women, about 60,000 of whom had at least one prescription for estrogen-only therapy, he said. The others took a combination of estrogen and progesterone or estrogen plus an androgen (male hormone).

During the study period, about 2 percent of the women developed a common form of glaucoma known as primary open angle glaucoma, Stein said, which develops when pressure builds up in the eye. Glaucoma refers to a group of eye diseases that damage the optic nerve and can lead to blindness. Treatment can help preserve vision.

Each month of estrogen use reduced the risk of glaucoma by 0.4 percent, and that risk reduction accumulated over time, Stein said. After four years of continuous use, the reduction in risk would be about 19 percent, he said.

Although the researchers found an association between the use of estrogen-only therapy and a reduced risk for this form of glaucoma, they did not prove a cause-and-effect link. No link was found for the other hormone regimens.

The study was published online Jan. 30 in the journal JAMA Ophthalmology.

Estrogen might work by lowering the pressure or by protecting certain cells in the eye, the researchers said.

Hormone-replacement therapy has been linked with increased health risks, such as heart disease, breast cancer and stroke. One 10-year follow-up of the Women's Health Initiative estrogen-only trial, however, found a reversal of the health risks among women who'd had a hysterectomy.

The new study results do not suggest that reducing the risk of glaucoma is reason enough to take hormone replacement therapy, said Dr. Angela Turalba, a glaucoma specialist at the Massachusetts Eye and Ear Infirmary.

Rather, the findings may prompt drug companies to begin looking at estrogen as a glaucoma treatment, said Turalba, who reviewed the research. "The findings are most helpful in guiding research in drug development for hormone-based therapies to be used as neuro-protective agents," she said.

Stein agreed. He said the goal would be to encourage drug companies to develop topical estrogen derivatives and study them as a glaucoma-preventive therapy.

The focus of the study was on women, he said, so there is no way to know whether estrogen-based treatments would also help men reduce glaucoma risk.

More information

To learn more about glaucoma, visit the Glaucoma Research Foundation.Copyright © 2014 HealthDay. All rights reserved.


SOURCES: Joshua Stein, M.D., assistant professor of ophthalmology, University of Michigan, Ann Arbor; Angela Turalba, M.D., glaucoma specialist, Massachusetts Eye and Ear Infirmary, Boston; Jan. 30, 2014, JAMA Ophthalmology, online...

InteliHealth
.
.
.
.
.
More News
InteliHealth .
.
General Health News
Today's News
Today In Health History
This Week In Health
Addiction News
Allergy News
Alzheimer's News
Arthritis News
Asthma News
Babies News
Breast Cancer News
Bronchitis News
Cancer News
Cervical Cancer News
Children's Health News
Cholesterol News
Dental/Oral Health News
Depression News
Diabetes News
Ear, Nose And Throat News
Environmental Health News
Eye News
Fitness News
Genetics News
Headache News
Health Policy News
Heart Attack News
Heart Failure News
Heart Health News
HIV/AIDS News
Infectious Diseases News
Influenza News
Lung Cancer News
Medication News
Men's Health News
Mental Health News
Multiple Sclerosis News
Nutrition News
Parkinson's News
Pregnancy News
Prostate Cancer News
Schizophrenia
Senior Health News
Sexual/Reproductive Health News
Sexual dysfunction
Sleep News
STDs News
Stroke News
Tobacco Cessation News
Weight Management News
Women's Health News
.
.
.
.
InteliHealth
    Print Printer-friendly format    
   
.  
This website is certified by Health On the Net Foundation. Click to verify.
.